Doctor of Philosophy (For Research in Healthy Society)



The Peak of Research Excellence in Healthy Society (Healthy Living, Active Ageing), previously Future Healthcare Peak of Excellence for AY2013-2015, has emerged as  a very prominent Peak especially with the establishment of the Lee Kong Chian School of Medicine. The Peak serves as a coordinating platform at the convergence of medicine, health, engineering, technology, science, business and humanities that integrates research, education and innovation to address the challenge faced by rapidly ageing societies including Singapore. The Peak will work towards promoting healthy living and mitigating the impact of ageing through technological innovations in human health and medicine. In addition, it will strengthen clinical interface for research with multiple healthcare institutions such as National Healthcare Group and Singapore Health Services to advance healthcare in Singapore. Endless opportunities await the Healthy Society candidates who are passionate about making an impact on Singapore's health system and ultimately, changing people's lives for the better.

Pursue your PhD research with one of the research centre listed below.




ARISE is a pan-university research institute that supports multidisciplinary research devoted to aged and ageing-related research, programmes and activities. Leveraging on NTU's strengths in engineering and technology, and working with engineering, business and medical schools, ARISE will focus on emergent research in medicine, social sciences, technologies and media. Through fundamental and translational research conducted in partnership with health agencies, eldercare service providers and industry partners, ARISE aims to drive Singapore's vision for an active, confident and productive ageing nation - contributing to sustainable high-quality eldercare, and independent and meaningful lifestyles for the elderly. ARISE aspires to nurture world-class talents and place Singapore at the forefront of ageing-related research.
Learn more about ARISE at and their research here.



The NTU Institute for Health Technologies (HealthTech NTU) accelerates the development and translation of new technologies to solve health problems and improve quality of life.

Harnessing the breadth and depth of engineering that makes Nanyang Technological University one of the world's top universities, along with the progressive Lee Kong Chian School of Medicine, and Singapore's state-of-the-art health services, HealthTech NTU provides a place where excellence in health, science, engineering, business and policy converge.

We tackle health challenges with clinicla precision, cutting edge research infrastructure, and expert interdisciplinary teams. We help engineers and scientists deliver effective solutions and enable clinicians to provide better care. From nanomedicines to global health innovations, we are engineering the future of healthcare.

Learn more about HealthTech NTU at and their research here. ​




NNIN Logo_small.jpg


In 2014, Nanyang Technological University (NTU) is collaborating with International Institute of Nanotechnology (IIN), based in Northwestern University to establish the NTU-Northwestern Institute for Nanomedicine (NNIN), the first of its kind in South-east Asia. Both universities are putting in substantive investments in this multi-million dollar research institute that will focus on the medical application of nanotechnology. Nanomedicine is a relatively new discipline that combines nanomaterials-based detection and treatment of diseases and is expected to have the most profound impact and benefit to society, thus NNIN is poised to realise significant advances. NNIN will focus on developing innovative solutions in four key areas: diabetes, cardiovascular, ophthalmology and skin therapeutics. The institute will bring together scientists from both universities working collaboratively on research projects in the areas of disease diagnostics, timed-release therapeutics, and targeted drug delivery methods, with emphasis on cardiovascular, skin, ocular and endocrinological disease.

Learn more about NNIN at and their research here.